Back
Apellis Pharmaceuticals Stock Predictions
![](/images/offers/ims/large/offer5.jpg)
Today's Fastest Growing Company Might Surprise You
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
34
APLS
Apellis Pharmaceuticals
Last Price:
$28.67
Seasonality Move:
18.61%
7 Day Trial
ALL ACCESS PASS
$
7
![](/images/offers/ims/large/offer4.jpg)
Elon Musk Dreams, Mode Mobile Delivers
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Apellis Pharmaceuticals Stock Forecast
-
Over the next 52 weeks, Apellis Pharmaceuticals has on average historically risen by 29.5% based on the past 7 years of stock performance.
-
Apellis Pharmaceuticals has risen higher in 4 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.14%
-
Is Apellis Pharmaceuticals Stock Undervalued?The current Apellis Pharmaceuticals [APLS] share price is $28.68. The Score for APLS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Apellis Pharmaceuticals Stock Go Up Next Year?
-
Over the next 52 weeks, Apellis Pharmaceuticals has on average historically risen by 29.5% based on the past 7 years of stock performance.
Apellis Pharmaceuticals Stock Rating
Sell
34
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals overpriced?
-
Apellis Pharmaceuticals has risen higher in 4 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.14%
Apellis Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
apellis.com
52-Week Data
52-Week High:
71.90
52-Week Low:
24.34
Prediction Charts
Market Cap:
3.6B
Price in USD:
28.68
Volume:
1.3M
Beta:
0.88
Technical Analysis
SMA50:
31.84
SMA100:
30.42
SMA200:
35.27
52-Wk Change:
-58.17%
Stock Predictions
-
Is Apellis Pharmaceuticals stock public?Yes, Apellis Pharmaceuticals is a publicly traded company.
-
What is the Apellis Pharmaceuticals stock quote today?The Apellis Pharmaceuticals stock price is 28.68 USD today.
-
How to buy Apellis Pharmaceuticals stock online?You can buy Apellis Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Jan-22 | 30.02 | 30.39 | 30.84 | 29.96 |
Jan-23 | 30.24 | 30.76 | 31.17 | 30.23 |
Jan-24 | 30.74 | 30.00 | 30.91 | 29.67 |
Jan-27 | 30.13 | 29.79 | 30.80 | 29.36 |
Jan-28 | 29.97 | 29.28 | 30.11 | 28.72 |
Jan-29 | 29.29 | 29.47 | 29.81 | 29.11 |
Jan-30 | 29.70 | 30.39 | 30.50 | 29.41 |
Jan-31 | 30.30 | 29.01 | 30.60 | 28.97 |
Feb-3 | 28.36 | 28.49 | 28.83 | 27.91 |
Feb-4 | 28.59 | 28.78 | 29.13 | 28.23 |
Feb-5 | 29.17 | 30.37 | 30.60 | 29.08 |
Feb-6 | 30.39 | 30.20 | 30.53 | 29.53 |
Feb-7 | 30.00 | 29.39 | 30.26 | 29.03 |
Feb-10 | 29.69 | 28.68 | 29.69 | 28.55 |
Apellis Pharmaceuticals Earnings
Apellis Pharmaceuticals Earnings Report: Per Share Apellis Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Apellis Pharmaceuticals Forecast Revenue Growth
Apellis Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Apellis Pharmaceuticals and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.69 per share, and an increase next year of $1.74 per share.
* Apellis Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.